Beijing: One of the coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Centre for Disease Control and Prevention (CDC) said.
China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential workers under an emergency use programme launched in July.
Phase 3 clinical trials for the vaccines were proceeding smoothly and one of them could be ready for the general public in November or December, CDC chief biosafety expert Guizhen Wu said in an interview with state TV late on Monday, news agency Reuters reported.
She, however, did not specify which vaccine she was referring to.
Wu said she has experienced no abnormal symptoms in recent months after taking an experimental vaccine herself in April.
A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and Sinovac Biotech are developing the three vaccines under China’s emergency use programme. A fourth COVID-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.
Sinopharm said in July that its vaccine could be ready for public use by the end of this year after the conclusion of Phase 3 trials.
